Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Department of Cardiology, The Affiliated Hospital of Qingdao University, China; Department of Urology, The Affiliated Hospital of Qingdao University, China; ...

In the study, the research team utilizes PandaOmics the AI-driven biological engine to identify novel targets and potential non-hormonal drug repurposing strategies for endometriosis treatment.

Blood pressure (BP) time in target range (TTR) reflects the proportion of time that BP measurement is within a specified target range. We aim to summarize the evidence for relationships between TTR ...

tissue inhibitor of matrix metalloproteases 1 (TIMP-1), lead to severe pulmonary remodeling. However, many other pro- and anti-inflammatory mediators are also altered in COPD which further ...

The progressive decline in cardiac function and structure is considered the main factor associated with declining prognosis in HF (3), leading to reverse remodeling, i.e., the reverse of these ...

Background: Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. Understanding the trends and factors ...

Results of the TARGET ... published in Hypertension in 2024, on renal denervation for the treatment of hypertension. According to the authors, “renal denervation presents a novel treatment ...